According to the Robert Koch Institute (RKI), the norovirus, which is widespread worldwide, is the cause of a large proportion of gastrointestinal infections. Those who catch the virus suffer from nausea, diarrhea and vomiting. It is very contagious and can spread quickly from person to person.
There is not much that can be done preventively beyond general hygiene rules. There is currently no vaccine against the norovirus. However, doctors have now begun to test the world’s first mRNA vaccine against the norovirus.
Norovirus vaccine based on mRNA technology is being tested
The vaccine is to undergo a phase three clinical trial called Nova 301. In two years, 25,000 people, mainly over 60 years old, from countries such as Japan, Canada and Australia are to be involved, reports the Guardian. Mobile teams are also to be used to make it easier for people to participate in the trial.
Half of the participants are to receive the new mRNA vaccine and the other half a saline solution as a placebo. The assignment follows at random.
Various institutions of the British National Health Service (NHS) and the pharmaceutical company Moderna, which manufactures the vaccine, are involved in the study. The norovirus vaccine is based on an mRNA technology with which the company Moderna, but also Pizer/Biontech, have already produced a vaccine against the corona virus.
In an earlier trial with the new norovirus vaccine, strong immune reactions are said to have already been detected in humans. The study is now about investigating whether the vaccine is effective against the virus itself and, if so, how long the protection lasts. “At least 65 percent (efficacy) or more is what we would consider clinically sensible,” the Guardian quotes Dr. Doran Fink of Moderna.
Norovirus is a threat to old and sick people
Norovirus outbreaks are common in hospitals, nursing homes, daycare centers or schools. Especially for very young or old people and for anyone who has a weakened immune system, an infection can have serious consequences. A successful vaccine would help ensure that operations in nursing homes could be maintained normally, says Prof. Saul Faust of the University of Southampton, according to the report.
General practitioner and study leader Dr. Patrick Moore emphasizes how high the burden of norovirus is. Worldwide, there are about 685 million cases and 200,000 deaths every year. In the UK, there are about four million cases a year.
It is hoped that a vaccine could bring health and economic benefits. “In the UK, norovirus costs the NHS an estimated £100 million a year [and] if you take into account the loss of earnings, it’s about £300 million,” says Moore.
If the result of the study is positive, it is expected that it will be possible to submit an application for approval for the vaccine in 2026. However, the review process would take another up to a year. In addition, further studies on teenagers and younger people would be needed.
News
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]
Scientists Discover Aspirin May Slash Dementia Risk by 70% – but Only for Certain People
Aspirin was linked to a sharply lower dementia risk in some older adults, and their genes may hold the clue. A Monash University analysis found that older adults with a particular genetic profile had [...]
Inflammation May Awaken Dormant Cancer Cells Years After Treatment
The body’s response to inflammation may disturb cancer cells that have been lying silent for years, giving them an opportunity to grow again. Researchers at the Francis Crick Institute have found that gut inflammation [...]
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]
Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to keep the virus suppressed when they received [...]
WHO Factsheets – The top 10 causes of death
In 2023, the 10 leading causes of death accounted for 33 million deaths, or 54% of the total 61 million deaths worldwide. The top global causes of death, in order of total number of lives lost, [...]
Aging Cells May Be Hiding From the Immune System – Scientists Think They Know How
Your immune system is supposed to clear out damaged cells. Researchers may have found how some of them hide and linger as the body ages. Researchers led by Cedars-Sinai Health Sciences University have identified [...]
